| 000 | 01794 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250517114641.0 | ||
| 264 | 0 | _c20170130 | |
| 008 | 201701s 0 0 eng d | ||
| 022 | _a1791-7530 | ||
| 024 | 7 |
_a10.21873/anticanres.11037 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKulda, Vlastimil | |
| 245 | 0 | 0 |
_aPrognostic Significance of TMPRSS2-ERG Fusion Gene in Prostate Cancer. _h[electronic resource] |
| 260 |
_bAnticancer research _c09 2016 |
||
| 300 |
_a4787-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _xbiosynthesis |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xbiosynthesis |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMicroRNAs _xbiosynthesis |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xblood |
| 650 | 0 | 4 |
_aOncogene Proteins, Fusion _xgenetics |
| 650 | 0 | 4 | _aParaffin Embedding |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aProstate _xpathology |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 | _aProstatectomy |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aTopolcan, Ondrej | |
| 700 | 1 | _aKucera, Radek | |
| 700 | 1 | _aKripnerova, Michaela | |
| 700 | 1 | _aSrbecka, Kristyna | |
| 700 | 1 | _aHora, Milan | |
| 700 | 1 | _aHes, Ondrej | |
| 700 | 1 | _aKlecka, Jiri | |
| 700 | 1 | _aBabuska, Vaclav | |
| 700 | 1 | _aRousarova, Milena | |
| 700 | 1 | _aBenson, Veronika | |
| 700 | 1 | _aPesta, Martin | |
| 773 | 0 |
_tAnticancer research _gvol. 36 _gno. 9 _gp. 4787-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.21873/anticanres.11037 _zAvailable from publisher's website |
| 999 |
_c26420516 _d26420516 |
||